US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 55.390
  • -1.800-3.15%
Close Jul 24 16:00 ET
  • 55.390
  • 0.0000.00%
Post 16:47 ET
4.70BMarket Cap-20514P/E (TTM)

CRISPR Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jul 24, 2024

Based on 16 analysts giving stock ratings to CRISPR Therapeutics in the past 3 months

Buy

  • Buy

    56.25%
  • Hold

    31.25%
  • Sell

    12.50%

Price Target

Updated: Jul 24, 2024

The average CRISPR Therapeutics stock price target is 76.79 with a max estimate of 105.00 and a min estimate of 30.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jul 24, 2024

Buy

  • Buy

    56.25%
  • Hold

    31.25%
  • Sell

    12.50%

Price Target

Updated: Jul 24, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg